Last updated: 14 November 2023 at 8:42pm EST

Thilo Schroeder Net Worth




The estimated Net Worth of Thilo Schroeder is at least $103 Milión dollars as of 7 March 2023. Thilo Schroeder owns over 650,000 units of Revolution Medicines Inc stock worth over $64,703,562 and over the last 5 years he sold RVMD stock worth over $38,335,404. In addition, he makes $0 as Independent Director at Revolution Medicines Inc.

Thilo Schroeder RVMD stock SEC Form 4 insiders trading

Thilo has made over 36 trades of the Revolution Medicines Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 650,000 units of RVMD stock worth $14,144,000 on 7 March 2023.

The largest trade he's ever made was buying 1,088,227 units of Revolution Medicines Inc stock on 18 February 2020 worth over $28,620,370. On average, Thilo trades about 107,947 units every 29 days since 2020. As of 7 March 2023 he still owns at least 1,553,134 units of Revolution Medicines Inc stock.

You can see the complete history of Thilo Schroeder stock trades at the bottom of the page.





Thilo Schroeder biography

Hr. Thilo Schroeder Ph.D. serves as Independent Director of the Company. Since January 2018, Dr. Schroeder has served as a member of the board of directors of IDEAYA Biosciences, Inc., an oncology-focused biotechnology company. He also serves as a member of the board of directors of ImaginAB, Inc., an immune-oncology imaging company. Dr. Schroeder also served as a member of the board of directors of Blueprint Medicines Corp., a biopharmaceutical company, from 2014 to May 2015. Prior to joining Nextech in 2012, Dr. Schroeder worked in research specializing on the development of Designed Ankyrin Repeat Proteins (DARPins) as specific protein inhibitors from 2007 to 2012. Dr. Schroeder received a B.S. in Biology from the Technical University of Darmstadt in Germany, an M.S. in Biotechnology from the École de Supérieure de Biotechnologie de Strasbourg in France, and a Ph.D. in Biochemistry from the University of Zurich in Switzerland. Schroeder’s educational background, his experience as a board member of biotechnology and pharmaceutical companies, and his experience as an investor in life sciences companies provide him with the qualifications and skills necessary to serve as a member of our board of directors.



How old is Thilo Schroeder?

Thilo Schroeder is 38, he's been the Independent Director of Revolution Medicines Inc since 2018. There are 17 older and no younger executives at Revolution Medicines Inc. The oldest executive at Revolution Medicines Inc is Elizabeth Anderson, 62, who is the Independent Director.

What's Thilo Schroeder's mailing address?

Thilo's mailing address filed with the SEC is C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY, CA, 94063.

Insiders trading at Revolution Medicines Inc

Over the last 5 years, insiders at Revolution Medicines Inc have traded over $249,645,422 worth of Revolution Medicines Inc stock and bought 3,371,315 units worth $74,500,278 . The most active insiders traders include Peter Svennilson, Thilo Schroeder a Rock Ventures Ii, L.P.Third.... On average, Revolution Medicines Inc executives and independent directors trade stock every 11 days with the average trade being worth of $3,075,216. The most recent stock trade was executed by Stephen Michael Kelsey on 13 August 2024, trading 16,667 units of RVMD stock currently worth $68,168.



What does Revolution Medicines Inc do?

revolution medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. we pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.



Complete history of Thilo Schroeder stock trades at Revolution Medicines Inc, Pmv Pharmaceuticals Inc a Silverback Therapeutics

Človek
Trans.
Transakcia
Celková cena
Thilo Schroeder
Kúpa $14,144,000
7 Mar 2023
Thilo Schroeder
Kúpa $5,000,000
22 Jul 2022
Thilo Schroeder
Kúpa $1,059,153
25 Mar 2022
Thilo Schroeder
Kúpa $5,490,761
22 Mar 2022
Thilo Schroeder
Kúpa $3,428,240
17 Mar 2022
Thilo Schroeder
Kúpa $897,611
10 Mar 2022
Thilo Schroeder
Kúpa $4,660,143
7 Mar 2022
Thilo Schroeder
Kúpa $28,620,370
18 Feb 2020
Thilo Schroeder
Riaditeľ
Predaj $24,120
6 Oct 2021
Thilo Schroeder
Riaditeľ
Predaj $439,886
30 Sep 2021
Thilo Schroeder
Riaditeľ
Predaj $224,278
27 Sep 2021
Thilo Schroeder
Riaditeľ
Predaj $3,000
22 Sep 2021
Thilo Schroeder
Riaditeľ
Predaj $21,351
17 Sep 2021
Thilo Schroeder
Riaditeľ
Predaj $2,153,879
9 Sep 2021
Thilo Schroeder
Riaditeľ
Predaj $1,418,907
31 Aug 2021
Thilo Schroeder
Riaditeľ
Predaj $1,791,343
26 Aug 2021
Thilo Schroeder
Riaditeľ
Predaj $1,600,733
23 Aug 2021
Thilo Schroeder
Riaditeľ
Predaj $1,013,445
18 Aug 2021
Thilo Schroeder
Riaditeľ
Predaj $2,727,840
13 Aug 2021
Thilo Schroeder
Riaditeľ
Predaj $2,352,973
10 Aug 2021
Thilo Schroeder
Riaditeľ
Predaj $2,814,817
5 Aug 2021
Thilo Schroeder
Riaditeľ
Predaj $3,369,567
2 Aug 2021
Thilo Schroeder
Riaditeľ
Predaj $394,108
28 Jul 2021
Thilo Schroeder
Riaditeľ
Predaj $623,469
23 Jul 2021
Thilo Schroeder
Riaditeľ
Predaj $675,995
21 Jul 2021
Thilo Schroeder
Riaditeľ
Predaj $182,580
28 May 2021
Thilo Schroeder
Riaditeľ
Predaj $572,819
25 May 2021
Thilo Schroeder
Riaditeľ
Predaj $1,608,498
20 May 2021
Thilo Schroeder
Riaditeľ
Predaj $63,742
10 May 2021
Thilo Schroeder
Riaditeľ
Predaj $21,384
5 May 2021
Thilo Schroeder
Riaditeľ
Predaj $1,014,874
9 Apr 2021
Thilo Schroeder
Riaditeľ
Predaj $4,681,119
6 Apr 2021
Thilo Schroeder
Riaditeľ
Predaj $2,038,920
1 Apr 2021
Thilo Schroeder
Riaditeľ
Predaj $1,857,479
29 Mar 2021
Thilo Schroeder
Riaditeľ
Predaj $4,644,278
24 Mar 2021
Thilo Schroeder
Riaditeľ
Kúpa $5,000,016
8 Dec 2020


Revolution Medicines Inc executives and stock owners

Revolution Medicines Inc executives and other stock owners filed with the SEC include: